Clinical trial NCT03261336 - References

Castration-resistant Prostate Cancer — Oral Calcitriol With Ketoconazole in CRPC

Citation(s)

•   Agoulnik IU, Krause WC, Bingman WE 3rd, Rahman HT, Amrikachi M, Ayala GE, Weigel NL
  Repressors of androgen and progesterone receptor action. J Biol Chem. 2003 Aug 15;278(33):31136-48. Epub 2003 May 27.
•   Ahmed S, Johnson CS, Rueger RM, Trump DL
  Calcitriol (1,25-dihydroxycholecalciferol) potentiates activity of mitoxantrone/dexamethasone in an androgen independent prostate cancer model. J Urol. 2002 Aug;168(2):756-61.
•   Akeno N, Matsunuma A, Maeda T, Kawane T, Horiuchi N
  Regulation of vitamin D-1alpha-hydroxylase and -24-hydroxylase expression by dexamethasone in mouse kidney. J Endocrinol. 2000 Mar;164(3):339-48.
•   Bareis P, Bises G, Bischof MG, Cross HS, Peterlik M
  25-hydroxy-vitamin d metabolism in human colon cancer cells during tumor progression. Biochem Biophys Res Commun. 2001 Jul 27;285(4):1012-7.
•   Barletta F, Freedman LP, Christakos S
  Enhancement of VDR-mediated transcription by phosphorylation: correlation with increased interaction between the VDR and DRIP205, a subunit of the VDR-interacting protein coactivator complex. Mol Endocrinol. 2002 Feb;16(2):301-14.
•   Beer TM, Eilers KM, Garzotto M, et al
  Androgen-independent prostate Cancer (AIPC) treatment with weekly high-dose calcitriol and docetaxel. Amer Soc Clin Oncol 21 177a (2002).
•   Beer TM, Munar M, Henner WD
  A Phase I trial of pulse calcitriol in patients with refractory malignancies: pulse dosing permits substantial dose escalation. Cancer. 2001 Jun 15;91(12):2431-9.
•   Bernardi RJ, Trump DL, Yu WD, McGuire TF, Hershberger PA, Johnson CS
  Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling. Clin Cancer Res. 2001 Dec;7(12):4164-73.
•   Biggs JR, Kraft AS
  Inhibitors of cyclin-dependent kinase and cancer. J Mol Med (Berl). 1995 Oct;73(10):509-14. Review.
•   Bikle DD, Pillai S
  Vitamin D, calcium, and epidermal differentiation. Endocr Rev. 1993 Feb;14(1):3-19. Review.
•   Bouillon R, Okamura WH, Norman AW
  Structure-function relationships in the vitamin D endocrine system. Endocr Rev. 1995 Apr;16(2):200-57. Review.
•   Cadepond F, Ulmann A, Baulieu EE
  RU486 (mifepristone): mechanisms of action and clinical uses. Annu Rev Med. 1997;48:129-56. Review.
•   Chen TL, Cone CM, Morey-Holton E, Feldman D
  Glucocorticoid regulation of 1,25(OH)2-vitamin D3 receptors in cultured mouse bone cells. J Biol Chem. 1982 Nov 25;257(22):13564-9.
•   Christakos S, Raval-Pandya M, Wernyj RP, Yang W
  Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3. Biochem J. 1996 Jun 1;316 ( Pt 2):361-71. Review. Erratum in: Biochem J 1996 Sep 15;318(Pt 3):1079.
•   Colston KW, Chander SK, Mackay AG, Coombes RC
  Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro. Biochem Pharmacol. 1992 Aug 18;44(4):693-702.
•   Cunningham D, Gilchrist NL, Cowan RA, Forrest GJ, McArdle CS, Soukop M
  Alfacalcidol as a modulator of growth of low grade non-Hodgkin's lymphomas. Br Med J (Clin Res Ed). 1985 Oct 26;291(6503):1153-5.
•   Darwish H, DeLuca HF
  Vitamin D-regulated gene expression. Crit Rev Eukaryot Gene Expr. 1993;3(2):89-116. Review.
•   Darwish HM, DeLuca HF
  Recent advances in the molecular biology of vitamin D action. Prog Nucleic Acid Res Mol Biol. 1996;53:321-44. Review.
•   Davies M
  High-dose vitamin D therapy: Indications, benefits and hazards. IN: Elevated Dosages of vitamins. P Walter, G Brubacher, H Stahelin (eds) Hans Humber, Lewistown, NY 81 (1989).
•   de Boland AR, Morelli S, Boland R
  1,25(OH)2-vitamin D3 signal transduction in chick myoblasts involves phosphatidylcholine hydrolysis. J Biol Chem. 1994 Mar 25;269(12):8675-9.
•   de Boland AR, Norman A
  Evidence for involvement of protein kinase C and cyclic adenosine 3',5' monophosphate-dependent protein kinase in the 1,25-dihydroxy-vitamin D3-mediated rapid stimulation of intestinal calcium transport, (transcaltachia). Endocrinology. 1990 Jul;127(1):39-45.
•   Dent P, Grant S
  Pharmacologic interruption of the mitogen-activated extracellular-regulated kinase/mitogen-activated protein kinase signal transduction pathway: potential role in promoting cytotoxic drug action. Clin Cancer Res. 2001 Apr;7(4):775-83. Review.
•   Elbashir SM, Harborth J, Weber K, Tuschl T
  Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods. 2002 Feb;26(2):199-213.
•   Evans RM
  The steroid and thyroid hormone receptor superfamily. Science. 1988 May 13;240(4854):889-95. Review.
•   Fakih M, Johnson CS, Trump DL
  Glucocorticoids and treatment of prostate cancer: a preclinical and clinical review. Urology. 2002 Oct;60(4):553-61. Review.
•   Feldman D
  Ketoconazole and other imidazole derivatives as inhibitors of steroidogenesis. Endocr Rev. 1986 Nov;7(4):409-20. Review.
•   Fillippovich I, Sorokina N, Gatei M, Haupt Y, Hobson K, Moallem E, Spring K, Mould M, McGuckin MA, Lavin MF, Khanna KK
  Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53. Oncogene. 2001 Jan 25;20(4):514-22.
•   Frappart L, Falette N, Lefebvre MF, Bremond A, Vauzelle JL, Saez S
  In vitro study of effects of 1,25 dihydroxyvitamin D3 on the morphology of human breast cancer cell line BT.20. Differentiation. 1989 Mar;40(1):63-9.
•   Gniadecki R
  Activation of Raf-mitogen-activated protein kinase signaling pathway by 1,25-dihydroxyvitamin D3 in normal human keratinocytes. J Invest Dermatol. 1996 Jun;106(6):1212-7.
•   Godyn JJ, Xu H, Zhang F, Kolla S, Studzinski GP
  A dual block to cell cycle progression in HL60 cells exposed to analogues of vitamin D3. Cell Prolif. 1994 Jan;27(1):37-46.
•   Gregory CW, Kim D, Ye P, D'Ercole AJ, Pretlow TG, Mohler JL, French FS
  Androgen receptor up-regulates insulin-like growth factor binding protein-5 (IGFBP-5) expression in a human prostate cancer xenograft. Endocrinology. 1999 May;140(5):2372-81.
•   Haynes RC
  Agents affecting calcification: calcium, parathyroid hormone, calcitonin, vitamin D, and other compounds. The Pharmacological Basis of Therapeutics. Gilman AG, Rall TW, Nies AS, Taylor P (eds). New York Pergamon Press 1496 (1990).
•   Henkart PA
  ICE family proteases: mediators of all apoptotic cell death? Immunity. 1996 Mar;4(3):195-201. Review.
•   Henry HL
  The 25(OH)D(3)/1alpha,25(OH)(2)D(3)-24R-hydroxylase: a catabolic or biosynthetic enzyme? Steroids. 2001 Mar-May;66(3-5):391-8. Review.
•   Herdick M, Carlberg C
  Agonist-triggered modulation of the activated and silent state of the vitamin D(3) receptor by interaction with co-repressors and co-activators. J Mol Biol. 2000 Dec 15;304(5):793-801.
•   Hershberger PA, McGuire TF, Yu WD, Zuhowski EG, Schellens JH, Egorin MJ, Trump DL, Johnson CS
  Cisplatin potentiates 1,25-dihydroxyvitamin D3-induced apoptosis in association with increased mitogen-activated protein kinase kinase kinase 1 (MEKK-1) expression. Mol Cancer Ther. 2002 Aug;1(10):821-9.
•   Hershberger PA, Modzelewski RA, Rueger RM, Blum KE, Trump DL, and Johnson CS
  Enhanced anti-tumor efficacy with dexamethasone/calcitriol/cisplatin therapy: role of P21WAF1. Proc. Amer. Assoc. Cancer Res. 41, 15 (2000).
•   Hershberger PA, Modzelewski RA, Shurin ZR, Rueger RM, Trump DL, Johnson CS
  1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo. Cancer Res. 1999 Jun 1;59(11):2644-9.
•   Hershberger PA, Yu WD, Modzelewski RA, Rueger RM, Johnson CS, Trump DL
  Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis. Clin Cancer Res. 2001 Apr;7(4):1043-51.
•   Hirst M, Feldman D
  Glucocorticoids down-regulate the number of 1, 25-dihydroxyvitamin D3 receptors in mouse intestine. Biochem Biophys Res Commun. 1982 Apr 29;105(4):1590-6.
•   Hisamoto K, Ohmichi M, Kanda Y, Adachi K, Nishio Y, Hayakawa J, Mabuchi S, Takahashi K, Tasaka K, Miyamoto Y, Taniguchi N, Murata Y
  Induction of endothelial nitric-oxide synthase phosphorylation by the raloxifene analog LY117018 is differentially mediated by Akt and extracellular signal-regulated protein kinase in vascular endothelial cells. J Biol Chem. 2001 Dec 14;276(50):47642-9. Epub 2001 Oct 10.
•   Hockenbery DM
  The bcl-2 oncogene and apoptosis. Semin Immunol. 1992 Dec;4(6):413-20. Review.
•   Johnson CS, Egorin MJ, Zuhowski R, 35 al
  Effects of high dose calcitriol (1,25 dihydroxyvitamin D3) on the pharmacokinetics of paclitaxel or carboplatin: results of two phase I studies Amer Soc Clin Oncol 19 210a (2000).
•   Kang S, Li XY, Duell EA, Voorhees JJ
  The retinoid X receptor agonist 9-cis-retinoic acid and the 24-hydroxylase inhibitor ketoconazole increase activity of 1,25-dihydroxyvitamin D3 in human skin in vivo. J Invest Dermatol. 1997 Apr;108(4):513-8.
•   Kantoff PW, Halabi S, Conaway M, Picus J, Kirshner J, Hars V, Trump D, Winer EP, Vogelzang NJ
  Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study. J Clin Oncol. 1999 Aug;17(8):2506-13.
•   Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG
  Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 1993 Sep 1;53(17):3976-85.
•   Khare S, Tien XY, Wilson D, Wali RK, Bissonnette BM, Scaglione-Sewell B, Sitrin MD, Brasitus TA
  The role of protein kinase-C alpha in the activation of particulate guanylate cyclase by 1 alpha,25-dihydroxyvitamin D3 in CaCo-2 cells. Endocrinology. 1994 Jul;135(1):277-83.
•   Kim D, Gregory CW, French FS, Smith GJ, Mohler JL
  Androgen receptor expression and cellular proliferation during transition from androgen-dependent to recurrent growth after castration in the CWR22 prostate cancer xenograft. Am J Pathol. 2002 Jan;160(1):219-26.
•   Kimberg DV, Baerg RD, Gershon E, Graudusius RT
  Effect of cortisone treatment on the active transport of calcium by the small intestine. J Clin Invest. 1971 Jun;50(6):1309-21.
•   Klein RG, Arnaud SB, Gallagher JC, Deluca HF, Riggs BL
  Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose. J Clin Invest. 1977 Jul;60(1):253-9.
•   Koeffler HP, Hirji K, Itri L
  1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells. Cancer Treat Rep. 1985 Dec;69(12):1399-407.
•   Kuo MH, Allis CD
  In vivo cross-linking and immunoprecipitation for studying dynamic Protein:DNA associations in a chromatin environment. Methods. 1999 Nov;19(3):425-33. Review.
•   Kurahashi I, Matsunuma A, Kawane T, Abe M, Horiuchi N
  Dexamethasone enhances vitamin D-24-hydroxylase expression in osteoblastic (UMR-106) and renal (LLC-PK1) cells treated with 1alpha,25-dihydroxyvitamin D3. Endocrine. 2002 Mar;17(2):109-18.
•   Levrero M, De Laurenzi V, Costanzo A, Gong J, Wang JY, Melino G
  The p53/p63/p73 family of transcription factors: overlapping and distinct functions. J Cell Sci. 2000 May;113 ( Pt 10):1661-70. Review.
•   Levy J, Zuili I, Yankowitz N, Shany S
  Induction of cytosolic receptors for 1 alpha, 25-dihydroxyvitamin D3 in the immature rat uterus by oestradiol. J Endocrinol. 1984 Mar;100(3):265-9.
•   Lewis TS, Shapiro PS, Ahn NG
  Signal transduction through MAP kinase cascades. Adv Cancer Res. 1998;74:49-139. Review.
•   Light BW, Yu WD, McElwain MC, Russell DM, Trump DL, Johnson CS
  Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system. Cancer Res. 1997 Sep 1;57(17):3759-64.
•   Liu M, Lee MH, Cohen M, Bommakanti M, Freedman LP
  Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 1996 Jan 15;10(2):142-53.
•   Ly LH, Zhao XY, Holloway L, Feldman D
  Liarozole acts synergistically with 1alpha,25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity. Endocrinology. 1999 May;140(5):2071-6.
•   Mabuchi S, Ohmichi M, Kimura A, Hisamoto K, Hayakawa J, Nishio Y, Adachi K, Takahashi K, Arimoto-Ishida E, Nakatsuji Y, Tasaka K, Murata Y
  Inhibition of phosphorylation of BAD and Raf-1 by Akt sensitizes human ovarian cancer cells to paclitaxel. J Biol Chem. 2002 Sep 6;277(36):33490-500. Epub 2002 Jun 26.
•   MacDonald PN, Baudino TA, Tokumaru H, Dowd DR, Zhang C
  Vitamin D receptor and nuclear receptor coactivators: crucial interactions in vitamin D-mediated transcription. Steroids. 2001 Mar-May;66(3-5):171-6. Review.
•   Mandic A, Viktorsson K, Molin M, Akusjärvi G, Eguchi H, Hayashi SI, Toi M, Hansson J, Linder S, Shoshan MC
  Cisplatin induces the proapoptotic conformation of Bak in a deltaMEKK1-dependent manner. Mol Cell Biol. 2001 Jun;21(11):3684-91.
•   Mangelsdorf DJ, Koeffler HP, Donaldson CA, Pike JW, Haussler MR
  1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. J Cell Biol. 1984 Feb;98(2):391-8.
•   McElwain MC, Dettlebach MA, Modzelewski RA, et al
  Antiproliferative effects in vitro and in vivo of 1,25-dihydroxyvitamin D3 and a vitamin D3 analog in a squamous cell carcinoma model system Mol Cell Diff 3 (1) 31 (1995).
•   McGuire TF, Trump DL and Johnson CS
  1,25-dihydroxyvitamin D3 induces cytosolic accumulation of MEKK-1 before onset of apoptosis in a p38 MAPK-regulated manner. Proc. Amer. Assoc. Cancer Res. 2159, 435 (2002).
•   McGuire TF, Trump DL, Johnson CS
  Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1. J Biol Chem. 2001 Jul 13;276(28):26365-73. Epub 2001 Apr 30.
•   Miller GJ, Stapleton GE, Hedlund TE, Moffat KA
  Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines. Clin Cancer Res. 1995 Sep;1(9):997-1003.
•   Modzelewski RA
  Apoptotic effects of paclitaxel and calcitriol in rat dunning MLL and human PC-3 prostate tumor cells in vitro. Proc Amer Assoc Cancer Res 40 580, 1999.
•   Mohler JL, Morris TL, Ford OH 3rd, Alvey RF, Sakamoto C, Gregory CW
  Identification of differentially expressed genes associated with androgen-independent growth of prostate cancer. Prostate. 2002 Jun 1;51(4):247-55.
•   Muindi JR, Modzelewski RA, Peng Y, Hershberger PA, Trump DL and Johnson CS
  Plasma 1, 25-dihydroxycholecalciferol pharmacokinetics in normal and tumor bearing mice. Oncology (in press).
•   Muindi JR, Peng Y, Potter DM, Hershberger PA, Tauch JS, Capozzoli MJ, Egorin MJ, Johnson CS, Trump DL
  Pharmacokinetics of high-dose oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxel. Clin Pharmacol Ther. 2002 Dec;72(6):648-59.
•   Nishimura K, Nonomura N, Satoh E, Harada Y, Nakayama M, Tokizane T, Fukui T, Ono Y, Inoue H, Shin M, Tsujimoto Y, Takayama H, Aozasa K, Okuyama A
  Potential mechanism for the effects of dexamethasone on growth of androgen-independent prostate cancer. J Natl Cancer Inst. 2001 Nov 21;93(22):1739-46.
•   Norman AW, Nemere I, Zhou LX, Bishop JE, Lowe KE, Maiyar AC, Collins ED, Taoka T, Sergeev I, Farach-Carson MC
  1,25(OH)2-vitamin D3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways. J Steroid Biochem Mol Biol. 1992 Mar;41(3-8):231-40. Review.
•   OH WK
  Secondary hormonal therapies in the treatment of prostate cancer. Urology. 2002 Sep;60(3 Suppl 1):87-92; discussion 93. Review.
•   Omdahl JL, Bobrovnikova EA, Choe S, Dwivedi PP, May BK
  Overview of regulatory cytochrome P450 enzymes of the vitamin D pathway. Steroids. 2001 Mar-May;66(3-5):381-9. Review.
•   Paul A, Wilson S, Belham CM, Robinson CJ, Scott PH, Gould GW, Plevin R
  Stress-activated protein kinases: activation, regulation and function. Cell Signal. 1997 Sep;9(6):403-10. Review.
•   Peehl DM, Seto E, Hsu JY, Feldman D
  Preclinical activity of ketoconazole in combination with calcitriol or the vitamin D analogue EB 1089 in prostate cancer cells. J Urol. 2002 Oct;168(4 Pt 1):1583-8.
•   Petkovich PM, Heersche JN, Tinker DO, Jones G
  Retinoic acid stimulates 1,25-dihydroxyvitamin D3 binding in rat osteosarcoma cells. J Biol Chem. 1984 Jul 10;259(13):8274-80.
•   Reinhardt TA, Horst RL
  Ketoconazole inhibits self-induced metabolism of 1,25-dihydroxyvitamin D3 and amplifies 1,25-dihydroxyvitamin D3 receptor up-regulation in rat osteosarcoma cells. Arch Biochem Biophys. 1989 Aug 1;272(2):459-65.
•   Reinhardt TA, Horst RL
  Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo. Endocrinology. 1990 Aug;127(2):942-8.
•   Rigby WF, Noelle RJ, Krause K, Fanger MW
  The effects of 1,25-dihydroxyvitamin D3 on human T lymphocyte activation and proliferation: a cell cycle analysis. J Immunol. 1985 Oct;135(4):2279-86.
•   Rolla D, Paoletti E, Marsano L, Mulas D, Peloso G, Cannella G
  Effects of subcutaneous calcitriol administration on plasma calcium and parathyroid hormone concentrations in continuous ambulatory peritoneal dialysis uremic patients. Perit Dial Int. 1993;13(2):118-21.
•   Sakaki T, Sawada N, Abe D, Komai K, Shiozawa S, Nonaka Y, Nakagawa K, Okano T, Ohta M, Inouye K
  Metabolism of 26,26,26,27,27,27-F6-1alpha,25-dihydroxyvitamin D3 by CYP24: species-based difference between humans and rats. Biochem Pharmacol. 2003 Jun 15;65(12):1957-65.
•   Schuster I, Egger H, Bikle D, Herzig G, Reddy GS, Stuetz A, Stuetz P, Vorisek G
  Selective inhibition of vitamin D hydroxylases in human keratinocytes. Steroids. 2001 Mar-May;66(3-5):409-22.
•   Shabahang M, Buras RR, Davoodi F, Schumaker LM, Nauta RJ, Evans SR
  1,25-Dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition. Cancer Res. 1993 Aug 15;53(16):3712-8.
•   Sheikh MS, Rochefort H, Garcia M
  Overexpression of p21WAF1/CIP1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. Oncogene. 1995 Nov 2;11(9):1899-905.
•   Sherr CJ, Roberts JM
  Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 1995 May 15;9(10):1149-63. Review.
•   Simboli-Campbell M, Narvaez CJ, Tenniswood M, Welsh J
  1,25-Dihydroxyvitamin D3 induces morphological and biochemical markers of apoptosis in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol. 1996 Jul;58(4):367-76.
•   Slater SJ, Kelly MB, Taddeo FJ, Larkin JD, Yeager MD, McLane JA, Ho C, Stubbs CD
  Direct activation of protein kinase C by 1 alpha,25-dihydroxyvitamin D3. J Biol Chem. 1995 Mar 24;270(12):6639-43.
•   Small EJ, Marshall ME, Reyno L, et al
  Superiority of suramin plus hydrocortisone over placebo plus hydrocortisone: results of a multicenter, double-blind, phase II study in patients with hormone refractory prostate cancer. J Clin Oncol 17 308 (1998).
•   Smith DC, Johnson CS, Freeman CC, Muindi J, Wilson JW, Trump DL
  A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy. Clin Cancer Res. 1999 Jun;5(6):1339-45.
•   Smith ML
  Mdm2 sensitizes MCF7 breast cancer cells to cisplatin or carboplatin. Breast Cancer Res Treat. 1999 Nov;58(2):99-105.
•   Smitherman AB, Gregory CW, Mohler JL
  Apoptosis levels increase after castration in the CWR22 human prostate cancer xenograft. Prostate. 2003 Sep 15;57(1):24-31.
•   Smitherman AB, Mohler JL, Maygarden SJ, Ornstein DK
  Expression of annexin I, II and VII proteins in androgen stimulated and recurrent prostate cancer. J Urol. 2004 Feb;171(2 Pt 1):916-20.
•   Strom M, Sandgren ME, Brown TA, DeLuca HF
  1,25-Dihydroxyvitamin D3 up-regulates the 1,25-dihydroxyvitamin D3 receptor in vivo. Proc Natl Acad Sci U S A. 1989 Dec;86(24):9770-3.
•   Studzinski GP, McLane JA, Uskokovic MR
  Signaling pathways for vitamin D-induced differentiation: implications for therapy of proliferative and neoplastic diseases. Crit Rev Eukaryot Gene Expr. 1993;3(4):279-312. Review.
•   Tannock IF, Osoba D, Stockler MR, Ernst DS, Neville AJ, Moore MJ, Armitage GR, Wilson JJ, Venner PM, Coppin CM, Murphy KC
  Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. J Clin Oncol. 1996 Jun;14(6):1756-64.
•   Trump DL, Havlin KH, Messing EM, Cummings KB, Lange PH, Jordan VC
  High-dose ketoconazole in advanced hormone-refractory prostate cancer: endocrinologic and clinical effects. J Clin Oncol. 1989 Aug;7(8):1093-8.
•   Trump DL, Serafine S, Brufsky J, et al
  High dose calcitriol (1,25(OH)2 vitamin D3) + dexamethasone in androgen independent prostate cancer (AIPC). Amer Soc Clin Oncol 19 337a (2000).
•   Wang QM, Jones JB, Studzinski GP
  Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. Cancer Res. 1996 Jan 15;56(2):264-7.
•   Weigel NL
  Steroid hormone receptors and their regulation by phosphorylation. Biochem J. 1996 Nov 1;319 ( Pt 3):657-67. Review.
•   Xu HM, Tepper CG, Jones JB, Fernandez CE, Studzinski GP
  1,25-Dihydroxyvitamin D3 protects HL60 cells against apoptosis but down-regulates the expression of the bcl-2 gene. Exp Cell Res. 1993 Dec;209(2):367-74.
•   Yu WD, Chang MJ, Trump DL, Johnson CS
  Interleukin-1alpha synergistic in vivo enhancement of cyclophosphamide- and carboplatin-mediated antitumor activity. Cancer Immunol Immunother. 1997 Aug;44(6):316-22.
•   Yu WD, McElwain MC, Modzelewski RA, Russell DM, Smith DC, Trump DL, Johnson CS
  Enhancement of 1,25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasone. J Natl Cancer Inst. 1998 Jan 21;90(2):134-41.
•   Yu WD, Rueger RM, Fuller RW, Johnson CS, and Trump DL
  1,25-dihydroxycholecalciferol (calcitriol) enhancement of chemotherapeutic efficacy: synergistic effects by median dose effect. Proc. Amer. Assoc. Cancer Res. 42, 84 (2001).
•   Zhang C, Dowd DR, Staal A, Gu C, Lian JB, van Wijnen AJ, Stein GS, MacDonald PN
  Nuclear coactivator-62 kDa/Ski-interacting protein is a nuclear matrix-associated coactivator that may couple vitamin D receptor-mediated transcription and RNA splicing. J Biol Chem. 2003 Sep 12;278(37):35325-36. Epub 2003 Jul 2.
•   Zhao J, Tan BK, Marcelis S, Verstuyf A, Bouillon R
  Enhancement of antiproliferative activity of 1alpha,25-dihydroxyvitamin D3 (analogs) by cytochrome P450 enzyme inhibitors is compound- and cell-type specific. J Steroid Biochem Mol Biol. 1996 Feb;57(3-4):197-202.

A Phase II Study of Oral Calcitriol in Combination With Ketoconazole in Castration Resistant Prostate Cancer, Progressing Despite Primary ADT and Abiraterone

Details for clinical trial NCT03261336